Clinical Trial Update: ELEVATE High-Risk PCI Pivotal Study [NA]

View source ↗

Summary

The ELEVATE High-Risk Percutaneous Coronary Intervention pivotal study sponsored by Magenta Medical Ltd is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Magenta Medical Ltd. | Conditions: High-Risk Percutaneous Coronary Intervention (High-risk PCI) | NA | Status: RECRUITING